Tissue Diagnostics Market: By Product Type (Immunohistochemistry, In Situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology), By Application (Breast Cancer, Non-small Cell Lung Cancer, Prostate Cancer, Gastric Cancer, Other Cancers), By End-User (Hospitals, Research Laboratories, Pharmaceutical Organizations, Contract Research Organizations (CROs)) and Geography    

Purchase Option

$ 4400
$ 6600
$ 8900

Tissue Diagnostics Market size was valued at USD 19,907.1 million in 2022 and is poised to grow at a significant CAGR of 9.5% from 2023-29. An increase in the burden of disease among the population leads to a growing number of anatomic pathology tests requests to hospitals and independent laboratories etc. This is expected to boost the market for anatomic pathology services. In order to achieve sustainable development goals, access to high-quality and timely pathology and laboratory services is needed, and certain non-communicable diseases cannot be diagnosed only based on physical examination of clinical pathology. Hence, the number of test requests for anatomical pathology is increasing. According to the 2016 status report on In Vitro Diagnostic Testing in Medical Practice, the volume of laboratory testing is driven by clinical demand, and 66% of clinical decisions in the U.S. and Germany are based on anatomic pathology testing. Pathology and laboratory medicine comprise a mere 2.3% of the total healthcare spending. Despite this, pathology services are estimated to impact 70% -80% of the healthcare decisions. The pathology industry has started focusing on anatomic pathology due to industry fragmentation, high skilled nature of anatomic pathology services, and substantial historical growth in demand for anatomic pathology services despite payments cuts. This provides an opportunity for manufacturers of anatomic pathology solutions to invest in the independent pathology laboratories because demand for pathology services. The anatomic pathology segment is expected to contribute the highest revenue share of 75.4 percent in the tissue diagnostics market in 2020, owing to the vastly increased prevalence of chronic diseases worldwide, where this technology is used chiefly in tissue diagnostics. Moreover, an increasing number of hospitals are providing laboratory outreach programs which are expected to drive the growth of the anatomic pathology market.

Tissue Diagnostics Market key Developments:
  • In March 2021, Agilent Technologies Inc. announced that it has entered into a definitive agreement to acquire Resolution Bioscience Inc., a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions. The acquisition complements and expands Agilent's capabilities in NGS-based cancer diagnostics and provides the company with innovative technology to further serve the needs of the fast-growing precision medicine market.
  • In July 2021, BD (Becton, Dickinson and Company), a leading global medical technology company, announced it has acquired Tepha, Inc., a leading developer and manufacturer of a propriletary resorbable polymer technology.

Global Tissue Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.5%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Tissue Diagnostics Market Dynamics

The global tissue diagnostics market is mainly driven by the increasing prevalence of cancer advancements in diagnostics. Moreover, hospital outreach and physicians' labs increase the demand for anatomic pathology services. High cost and lack of penetration in developing economies and lack of health insurance act as growth restraints in the worldwide tissue diagnostics market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Tissue Diagnostics Market Segmentation

By Product
  • Immunohistochemistry,
  • In Situ Hybridization,
  • Primary & Special Staining,
  • Digital Pathology and Workflow,
  • Anatomic Pathology
By Application
  • Breast Cancer,
  • Non-small Cell Lung Cancer,
  • Prostate Cancer,
  • Gastric Cancer,
  • Other Cancers
By End-User
  • Hospitals,
  • Research Laboratories,
  • Pharmaceutical Organizations,
  • Contract Research Organizations (CROs)

Frequently Asked Questions

The tissue diagnostics market is projected to expand at a CAGR of 9.5% during the forecast period

Thermo Fisher Scientific (US), Agilent Technologies (US), Abbott Laboratories (US), Merck KGa(Germany), QIAGEN (Netherlands)

North America is the fastest-growing region for tissue diagnostics market

1. Executive Summary
2. Global Tissue Diagnostics Market Introduction
2.1. Global Tissue Diagnostics Market €“ Taxonomy
2.2. Global Tissue Diagnostics Market €“Definitions
2.2.1. By Technology & Product Type
2.2.2. By Application
2.2.3. By End User
2.2.4. By Region
3. Global Tissue Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Tissue Diagnostics Market Dynamic Factors - Impact Analysis
3.6. Global Tissue Diagnostics Market €“ Competition Landscape
4. Global Tissue Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Tissue Diagnostics Market, By Technology & Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1. Immunohistochemistry
5.1.1        Instruments
5.1.1.1   Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.1.2   Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3   Market Opportunity Analysis
5.1.2        Slide Staining Systems
5.1.2.1   Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2.2   Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3   Market Opportunity Analysis
5.1.3        Tissue Macro Arrays
5.1.3.1   Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.3.2   Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3   Market Opportunity Analysis
5.1.4        Tissue Processing Systems
5.1.4.1   Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.4.2   Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3   Market Opportunity Analysis
5.1.5        Slide Scanners
5.1.5.1   Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.5.2   Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.5.3   Market Opportunity Analysis
5.1.6        Consumables
5.1.6.1   Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.6.2   Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.6.3   Market Opportunity Analysis
5.1.7        Antibodies
5.1.7.1   Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.7.2   Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.7.3   Market Opportunity Analysis
5.1.8        Reagents
5.1.8.1   Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.8.2   Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.8.3   Market Opportunity Analysis
5.1.9        Kits & Probes
5.1.9.1   Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.9.2   Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.9.3   Market Opportunity Analysis
5.2. In-Situ Hybridization
5.2.1. Instruments
5.2.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Consumables
5.2.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Software
5.2.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
5.3. Primary and Special Staining
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Digital Pathology and Workflow
5.4.1. Whole Slide Imagining
5.4.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.1.3. Market Opportunity Analysis
5.4.2. Image Analysis Informatics
5.4.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.2.3. Market Opportunity Analysis
5.4.3. Information Management System Storage & Communication
5.4.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3.3. Market Opportunity Analysis
5.5. Anatomic Pathology
5.5.1. Instruments
5.5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.1.3. Market Opportunity Analysis
5.5.2. Microtomes & Cryostat Microtomes
5.5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.2.3. Market Opportunity Analysis
5.5.3. Tissue Processors
5.5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3.3. Market Opportunity Analysis
5.5.4. Automatic Strainers
5.5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.4.3. Market Opportunity Analysis
5.5.5. Consumables
5.5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.5.3. Market Opportunity Analysis
5.5.6. Reagents & Antibodies
5.5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.6.3. Market Opportunity Analysis
5.5.7. Probes & Kits
5.5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.7.3. Market Opportunity Analysis
6. Global Tissue Diagnostics Market Forecast, By Application, 2018 - 2022 and Forecast, 2023 - 2029
6.1. Breast Cancer
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Non- Small Cell Lung Cancer
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Prostate Cancer
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Gastric Cancer
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Other Cancers
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Tissue Diagnostics Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029
7.1. Hospitals
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Research Laboratories
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Pharmaceutical Organizations
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Contract Research Organizations (CROs)
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Tissue Diagnostics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Tissue Diagnostics Market - Opportunity Analysis Index, By Technology & Product Type, Application, End User, and Region, 2023 - 2029
9. North America Tissue Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. Technology & Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Immunohistochemistry
9.1.1.1. Instruments
9.1.1.2. Slide Staining Systems
9.1.1.3. Tissue Macro Arrays
9.1.1.4. Tissue Processing Systems
9.1.1.5. Slide Scanners
9.1.1.6. Consumables
9.1.1.7. Antibodies
9.1.1.8. Kits
9.1.1.9. Reagents
9.1.1.10. Probes
9.1.2. In Situ Hybridization
9.1.2.1. Instruments
9.1.2.2. Consumables
9.1.2.3. Software
9.1.3. Primary & Special Staining
9.1.4. Digital Pathology and Workflow
9.1.4.1. Whole Slide Imaging
9.1.4.2. Image Analysis Informatics
9.1.4.3. Information Management System Storage & Communication
9.1.5. Anatomic Pathology
9.1.5.1. Instruments
9.1.5.2. Microtomes & Cryostat microtomes
9.1.5.3. Tissue processors
9.1.5.4. Automatic strainers
9.1.5.5. Other products
9.1.5.6. Consumables
9.1.5.7. Reagents & Antibodies
9.1.5.8. Probes & Kits
9.1.5.9. Others
9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Breast Cancer
9.2.2. Non-small Cell Lung Cancer
9.2.3. Prostate Cancer
9.2.4. Gastric Cancer
9.2.5. Other Cancers
9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospitals
9.3.2. Research Laboratories
9.3.3. Pharmaceutical Organizations
9.3.4. Contract Research Organizations (CROs)
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Tissue Diagnostics Market - Opportunity Analysis Index, By Technology & Product Type, Application, End User and Country, 2023 - 2029
9.6. North America Tissue Diagnostics Market Dynamics €“ Trends
10. Europe Tissue Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. Technology & Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Immunohistochemistry
10.1.1.1. Instruments
10.1.1.2. Slide Staining Systems
10.1.1.3. Tissue Macro Arrays
10.1.1.4. Tissue Processing Systems
10.1.1.5. Slide Scanners
10.1.1.6. Consumables
10.1.1.7. Antibodies
10.1.1.8. Kits
10.1.1.9. Reagents
10.1.1.10. Probes
10.1.2. In Situ Hybridization
10.1.2.1. Instruments
10.1.2.2. Consumables
10.1.2.3. Software
10.1.3. Primary & Special Staining
10.1.4. Digital Pathology and Workflow
10.1.4.1. Whole Slide Imaging
10.1.4.2. Image Analysis Informatics
10.1.4.3. Information Management System Storage & Communication
10.1.5. Anatomic Pathology
10.1.5.1. Instruments
10.1.5.2. Microtomes & Cryostat microtomes
10.1.5.3. Tissue processors
10.1.5.4. Automatic strainers
10.1.5.5. Other products
10.1.5.6. Consumables
10.1.5.7. Reagents & Antibodies
10.1.5.8. Probes & Kits
10.1.5.9. Others
10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Breast Cancer
10.2.2. Non-small Cell Lung Cancer
10.2.3. Prostate Cancer
10.2.4. Gastric Cancer
10.2.5. Other Cancers
10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospitals
10.3.2. Research Laboratories
10.3.3. Pharmaceutical Organizations
10.3.4. Contract Research Organizations (CROs)
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Tissue Diagnostics Market - Opportunity Analysis Index, By Technology & Product Type, Application, End User and Country, 2023 - 2029
10.6. Europe Tissue Diagnostics Market Dynamics €“ Trends
11. Asia-Pacific Tissue Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. Technology & Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Immunohistochemistry
11.1.1.1. Instruments
11.1.1.2. Slide Staining Systems
11.1.1.3. Tissue Macro Arrays
11.1.1.4. Tissue Processing Systems
11.1.1.5. Slide Scanners
11.1.1.6. Consumables
11.1.1.7. Antibodies
11.1.1.8. Kits
11.1.1.9. Reagents
11.1.1.10. Probes
11.1.2. In Situ Hybridization
11.1.2.1. Instruments
11.1.2.2. Consumables
11.1.2.3. Software
11.1.3. Primary & Special Staining
11.1.4. Digital Pathology and Workflow
11.1.4.1. Whole Slide Imaging
11.1.4.2. Image Analysis Informatics
11.1.4.3. Information Management System Storage & Communication
11.1.5. Anatomic Pathology
11.1.5.1. Instruments
11.1.5.2. Microtomes & Cryostat microtomes
11.1.5.3. Tissue processors
11.1.5.4. Automatic strainers
11.1.5.5. Other products
11.1.5.6. Consumables
11.1.5.7. Reagents & Antibodies
11.1.5.8. Probes & Kits
11.1.5.9. Others
11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Breast Cancer
11.2.2. Non-small Cell Lung Cancer
11.2.3. Prostate Cancer
11.2.4. Gastric Cancer
11.2.5. Other Cancers
11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospitals
11.3.2. Research Laboratories
11.3.3. Pharmaceutical Organizations
11.3.4. Contract Research Organizations (CROs)
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Tissue Diagnostics Market - Opportunity Analysis Index, By Technology & Product Type, Application, End User and Country, 2023 - 2029
11.6. Asia-Pacific Tissue Diagnostics Market Dynamics €“ Trends
12. Latin America Tissue Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Technology & Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Immunohistochemistry
12.1.1.1. Instruments
12.1.1.2. Slide Staining Systems
12.1.1.3. Tissue Macro Arrays
12.1.1.4. Tissue Processing Systems
12.1.1.5. Slide Scanners
12.1.1.6. Consumables
12.1.1.7. Antibodies
12.1.1.8. Kits
12.1.1.9. Reagents
12.1.1.10. Probes
12.1.2. In Situ Hybridization
12.1.2.1. Instruments
12.1.2.2. Consumables
12.1.2.3. Software
12.1.3. Primary & Special Staining
12.1.4. Digital Pathology and Workflow
12.1.4.1. Whole Slide Imaging
12.1.4.2. Image Analysis Informatics
12.1.4.3. Information Management System Storage & Communication
12.1.5. Anatomic Pathology
12.1.5.1. Instruments
12.1.5.2. Microtomes & Cryostat microtomes
12.1.5.3. Tissue processors
12.1.5.4. Automatic strainers
12.1.5.5. Other products
12.1.5.6. Consumables
12.1.5.7. Reagents & Antibodies
12.1.5.8. Probes & Kits
12.1.5.9. Others
12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Breast Cancer
12.2.2. Non-small Cell Lung Cancer
12.2.3. Prostate Cancer
12.2.4. Gastric Cancer
12.2.5. Other Cancers
12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospitals
12.3.2. Research Laboratories
12.3.3. Pharmaceutical Organizations
12.3.4. Contract Research Organizations (CROs)
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Tissue Diagnostics Market - Opportunity Analysis Index, By Technology & Product Type, Application, and Country, 2023 - 2029
12.6. Latin America Tissue Diagnostics Market Dynamics €“ Trends
13. Middle East and Africa Tissue Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.1. Technology & Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Immunohistochemistry
13.1.1.1. Instruments
13.1.1.2. Slide Staining Systems
13.1.1.3. Tissue Macro Arrays
13.1.1.4. Tissue Processing Systems
13.1.1.5. Slide Scanners
13.1.1.6. Consumables
13.1.1.7. Antibodies
13.1.1.8. Kits
13.1.1.9. Reagents
13.1.1.10. Probes
13.1.2. In Situ Hybridization
13.1.2.1. Instruments
13.1.2.2. Consumables
13.1.2.3. Software
13.1.3. Primary & Special Staining
13.1.4. Digital Pathology and Workflow
13.1.4.1. Whole Slide Imaging
13.1.4.2. Image Analysis Informatics
13.1.4.3. Information Management System Storage & Communication
13.1.5. Anatomic Pathology
13.1.5.1. Instruments
13.1.5.2. Microtomes & Cryostat microtomes
13.1.5.3. Tissue processors
13.1.5.4. Automatic strainers
13.1.5.5. Other products
13.1.5.6. Consumables
13.1.5.7. Reagents & Antibodies
13.1.5.8. Probes & Kits
13.1.5.9. Others
13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Breast Cancer
13.2.2. Non-small Cell Lung Cancer
13.2.3. Prostate Cancer
13.2.4. Gastric Cancer
13.2.5. Other Cancers
13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospitals
13.3.2. Research Laboratories
13.3.3. Pharmaceutical Organizations
13.3.4. Contract Research Organizations (CROs)
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Tissue Diagnostics Market - Opportunity Analysis Index, By Technology & Product Type, Application, and Country, 2023 - 2029
13.6. MEA Tissue Diagnostics Market Dynamics €“ Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Technology & Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. F. Hoffmann-La Roche Ltd.
14.2.2. Abbott Laboratories
14.2.3. Siemens
14.2.4. Danaher
14.2.5. bioMérieux SA
14.2.6. QIAGEN
14.2.7. Becton Dickinson & Company
14.2.8. Merck KGaA
14.2.9. Epredia
14.2.10. Agilent Technologies, Inc.
14.2.11. GE Healthcare
14.2.12. BioGenex
14.2.13. Cell Signaling Technology, Inc.
14.2.14. Bio SB
14.2.15. DiaGenic ASA
14.2.16. Sakura Finetek Japan Co. Ltd.
14.2.17. Abcam plc
14.2.18. Enzo Life Sciences, Inc.
14.2.19. Master Diagnóstica
14.2.20. TissueGnostics GmbH
15. Research Methodology
16. Key Assumptions and Acronyms
  • Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Siemens
  • Danaher
  • bioMérieux SA
  • QIAGEN
  • Becton Dickinson & Company
  • Merck KGaA
  • Epredia
  • Agilent Technologies, Inc.
  • GE Healthcare
  • BioGenex
  • Cell Signaling Technology, Inc.
  • Bio SB
  • DiaGenic ASA
  • Sakura Finetek Japan Co. Ltd.
  • Abcam plc
  • Enzo Life Sciences, Inc.
  • Master Diagnóstica
  • TissueGnostics GmbH

Adjacent Markets